Pancreatic Cancer Research

ResearcherAcıbadem UniversityActive in the last 2 years

Çiğdem Usul Afşar

Matched on ORCID iD 0000-0002-3764-7639; OpenAlex author ID A5046370369. Sources: OpenAlex.

Their work

Papers
8 (first author 4, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2016: 3 papers · 2017: 1 paper · 2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 8

  1. The Relationship Between Metabolic and Inflammatory Parameters at the Time of Diagnosis and Disease Stage and Prognosis in Patients with Pancreatic Cancer. Co-author DOI 10.1089/met.2024.0210↗
  2. The Prognostic Value of the EASIX Score in Patients with Metastatic Pancreatic Cancer. Last author DOI 10.3390/diagnostics15141740↗
  3. Is there any diagnostic value of serum caveolin-1 levels on the determination of pancreatic adenocarcinoma? First author DOI 10.4103/jcrt.jcrt_469_23↗
  4. Clinical Significance of Serum NEDD9 Levels in Patients with Pancreatic Cancer. Co-author DOI 10.3390/biom8040169↗
  5. Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma. Co-author DOI 10.1016/j.jiac.2016.12.003↗
  6. Evaluation of Serum Interleukin-17 (IL-17) Levels as a Diagnostic Marker in Pancreatic Adenocarcinoma. First author DOI 10.1007/s12029-015-9787-z↗
  7. Clinical significance of serum omentin-1 levels in patients with pancreatic adenocarcinoma. First author DOI 10.1016/j.bbacli.2016.10.002↗
  8. Serum leptin levels may have diagnostic and predictive roles in patients with pancreatic adenocarcinoma treated with gemcitabine-based chemotherapy. First author PMID 27685911↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Senem Karabulut · 6 shared papers, 2016–2024 · strength 0.60
  2. Hanife Usta Atmaca · 1 shared paper, 2025 · strength 0.33
  3. Ozlem Yılmaz · 1 shared paper, 2025 · strength 0.33
  4. Faruk Taş · 4 shared papers, 2016–2018 · strength 0.29
  5. Vahit Can Çavdar · 1 shared paper, 2025 · strength 0.28
  6. İlkay Gültürk · 1 shared paper, 2025 · strength 0.28
  7. Didem Taştekin · 1 shared paper, 2024 · strength 0.26
  8. Nuri Faruk Aykan · 1 shared paper, 2016 · strength 0.06
  9. Kayhan Ertürk · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.